Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cristcot
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cristcot

Cristcot

Series B

Cristcot: Specializing in innovative drug delivery systems for gastroenterology, neurology, and pain management.

HQ
Concord, CA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Cristcot was founded with the mission to innovate drug delivery systems in the fields of gastroenterology, neurology, and pain management. The company's vision is to address significant gaps in disease management that are often overlooked by other pharmaceutical firms. Cristcot's flagship product, currently in Phase 3 clinical trials, aims to halt acute flares in ulcerative colitis, highlighting its focus on gastroenterology. The company also has a pipeline of future products targeting similar therapeutic areas.

Notable affiliated individuals and investors in Cristcot include key figures from the pharmaceutical industry, although specific names are not publicly disclosed. The company's significant achievement includes advancing its ulcerative colitis treatment to Phase 3 clinical trials, indicating promising efficacy and safety results. Cristcot's impact lies in its strategic approach to addressing unmet medical needs in specialized fields, potentially improving the quality of life for patients with chronic conditions.

Cristcot - Similar Companies

Crinetics Pharmaceuticals logo

Crinetics Pharmaceuticals

crinetics.com

Cotera logo

Cotera

Celtaxsys logo

Celtaxsys

celtaxsys.com

CytoAgents logo

CytoAgents

cytoagents.com

Crititech logo

Crititech

crititech.com

Control Delivery Systems logo

Control Delivery Systems

Neurocarrus logo

Neurocarrus

neurocarrus.com

Critical Biologics logo

Critical Biologics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Precision IBD logo

Precision IBD

Cara Therapeutics logo

Cara Therapeutics

Cogentus Pharmaceuticals logo

Cogentus Pharmaceuticals

CraniUS logo

CraniUS

craniusmed.com

Cytogel Pharma logo

Cytogel Pharma

cytogelpharma.com

Theracos logo

Theracos

theracos.com

Cristcot - Quick Facts

Who are Cristcot's competitors?

Companies similar to Cristcot include Crinetics Pharmaceuticals, Cotera, Celtaxsys and CytoAgents.

When was Cristcot founded?

Cristcot was founded in 2008.

Where is Cristcot's headquarters located?

Cristcot's headquarters is located in Concord, CA, US.

When was Cristcot's last funding round?

Cristcot's most recent funding round was for $13.7M (USD) in October 2019.

How much has Cristcot raised to-date?

As of Oct 23, 2019, Cristcot has raised a total of $22.5M (USD).

How many employees does Cristcot have?

Cristcot has 11 employees as of Feb 5, 2024.

Cristcot - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 3250Manufacture of medical and dental instruments and supplies
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 339000Miscellaneous Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies